Revance Therapeutics, Inc. (RVNC)

Revance Therapeutics Statistics

Total Valuation

RVNC has a market cap or net worth of $324.15 million. The enterprise value is $623.52 million.

Market Cap	324.15M
Enterprise Value	623.52M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

RVNC has 104.90 million shares outstanding. The number of shares has increased by 16.69% in one year.

Current Share Class	104.90M
Shares Outstanding	104.90M
Shares Change (YoY)	+16.69%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	80.95%
Float	96.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.16
Forward PS	1.02
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.12

Current Ratio	4.12
Quick Ratio	2.90
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-24.36%
Return on Capital (ROIC)	-34.49%
Revenue Per Employee	$430,394
Profits Per Employee	-$308,943
Employee Count	597
Asset Turnover	0.52
Inventory Turnover	2.33

Taxes

In the past 12 months, RVNC has paid $1.50 million in taxes.

Income Tax	1.50M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is 0.83, so RVNC's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-62.50%
50-Day Moving Average	4.37
200-Day Moving Average	4.37
Relative Strength Index (RSI)	33.47
Average Volume (20 Days)	3,648,129

Short Selling Information

The latest short interest is 12.70 million, so 12.11% of the outstanding shares have been sold short.

Short Interest	12.70M
Short Previous Month	12.21M
Short % of Shares Out	12.11%
Short % of Float	13.17%
Short Ratio (days to cover)	5.20

Income Statement

In the last 12 months, RVNC had revenue of $256.95 million and -$184.44 million in losses. Loss per share was -$1.91.

Revenue	256.95M
Gross Profit	103.69M
Operating Income	-193.71M
Pretax Income	-287.20M
Net Income	-184.44M
EBITDA	-187.62M
EBIT	-193.71M
Loss Per Share	-$1.91

Balance Sheet

The company has $184.08 million in cash and $483.45 million in debt, giving a net cash position of -$299.37 million or -$2.85 per share.

Cash & Cash Equivalents	184.08M
Total Debt	483.45M
Net Cash	-299.37M
Net Cash Per Share	-$2.85
Equity (Book Value)	-163.03M
Book Value Per Share	-1.55
Working Capital	249.64M

Cash Flow

In the last 12 months, operating cash flow was -$190.89 million and capital expenditures -$4.02 million, giving a free cash flow of -$194.91 million.

Operating Cash Flow	-190.89M
Capital Expenditures	-4.02M
Free Cash Flow	-194.91M
FCF Per Share	-$1.86

Margins

Gross margin is 40.35%, with operating and profit margins of -75.39% and -71.78%.

Gross Margin	40.35%
Operating Margin	-75.39%
Pretax Margin	-117.35%
Profit Margin	-71.78%
EBITDA Margin	-73.02%
EBIT Margin	-75.39%
FCF Margin	n/a

Dividends & Yields

RVNC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.69%
Shareholder Yield	-16.69%
Earnings Yield	-56.90%
FCF Yield	-60.13%

Analyst Forecast

The average price target for RVNC is $8.45, which is 173.46% higher than the current price. The consensus rating is "Hold".

Price Target	$8.45
Price Target Difference	173.46%
Analyst Consensus	Hold
Analyst Count	9
Revenue Growth Forecast (5Y)	21.62%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RVNC has an Altman Z-Score of -6.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.36
Piotroski F-Score	3